Australian Clinical Labs Limited (ASX:ACL)

Australian Clinical Labs Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 15, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	354	540	503	694	922	686
Market Cap Growth	-42.59%	7.36%	-27.51%	-24.69%	34.33%	-
Enterprise Value	646	834	805	1,001	1,160	940
Last Close Price	1.90	2.65	2.30	3.04	3.63	2.63
PE Ratio	13.44	16.66	21.03	19.34	5.17	11.37
Forward PE	10.98	13.94	13.83	15.92	9.64	7.42
PS Ratio	0.48	0.73	0.72	1.00	0.93	1.06
PB Ratio	2.34	3.14	2.83	4.02	3.96	8.38
P/TBV Ratio	-	87.92	39.99	95.82	13.75	-
P/FCF Ratio	2.26	3.10	3.29	5.08	3.51	4.75
P/OCF Ratio	2.15	2.96	3.15	4.83	3.25	4.46
PEG Ratio	2.22	0.74	3.00	-	-	-
EV/Sales Ratio	0.88	1.13	1.16	1.44	1.17	1.45
EV/EBITDA Ratio	3.17	10.26	10.55	12.56	4.05	6.80
EV/EBIT Ratio	9.41	12.27	12.87	15.35	4.24	7.34
EV/FCF Ratio	4.12	4.79	5.26	7.32	4.42	6.51
Debt / Equity Ratio	2.09	1.69	1.74	1.83	1.13	3.71
Debt / EBITDA Ratio	1.55	1.42	1.62	1.68	0.69	1.41
Debt / FCF Ratio	2.01	1.67	2.02	2.31	1.00	2.11
Net Debt / Equity Ratio	1.93	1.56	1.59	1.71	1.01	3.27
Net Debt / EBITDA Ratio	3.58	3.30	3.70	3.71	0.82	1.94
Net Debt / FCF Ratio	1.86	1.54	1.84	2.16	0.89	1.85
Asset Turnover	1.29	1.27	1.19	1.16	1.79	1.52
Inventory Turnover	28.26	28.99	27.72	25.32	32.71	32.71
Quick Ratio	0.42	0.44	0.52	0.51	0.53	0.60
Current Ratio	0.59	0.56	0.64	0.62	0.64	0.71
Return on Equity (ROE)	16.68%	18.77%	13.84%	17.79%	113.46%	80.04%
Return on Assets (ROA)	7.48%	7.28%	6.67%	6.75%	30.79%	18.82%
Return on Invested Capital (ROIC)	9.94%	10.29%	8.98%	10.40%	46.95%	29.52%
Return on Capital Employed (ROCE)	18.80%	19.00%	16.20%	16.70%	68.00%	40.20%
Earnings Yield	7.44%	6.00%	4.76%	5.17%	19.34%	8.80%
FCF Yield	44.32%	32.28%	30.42%	19.70%	28.51%	21.04%
Dividend Yield	6.91%	4.72%	5.23%	4.61%	14.59%	5.42%
Payout Ratio	92.80%	76.92%	83.35%	269.85%	13.59%	69.57%
Buyback Yield / Dilution	6.50%	4.63%	0.82%	0.18%	-32.47%	-4.65%
Total Shareholder Return	13.42%	9.36%	6.04%	4.79%	-17.87%	0.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.